Halozyme Therapeutics (HALO) Return on Assets [ROA] (2009 - 2026)
Halozyme Therapeutics (HALO) posted Return on Assets [ROA] of 15.75% for Q2 2026, down 10.47 percentage points from 26.22% a year earlier but up 2.33 percentage points from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For FY2025, Halozyme Therapeutics' Return on Assets [ROA] came in at 13.81%, down 9.58 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a five-year change of -8.72 percentage points (FY2020 to FY2025).
- In prior years, Halozyme Therapeutics' Return on Assets [ROA] was 23.39% in FY2024 (+7.64 pp), 15.75% in FY2023 (+2.03 pp), 13.72% in FY2022 (-34.10 pp) and 47.82% in FY2021 (+25.29 pp).
- Quarterly Return on Assets [ROA] has run from a low of 10.26% in Q1 2023 to a high of 38.38% in Q1 2022 over five years.
- On a year-over-year basis, Return on Assets [ROA] has declined in each of the last three quarters, with an average year-over-year change of +0.70 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2021, with a gain of 32.91 percentage points; the weakest was Q1 2023, with a drop of 28.12 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 13.42% (Q1 2026), 13.35% (Q4 2025) and 27.86% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Halozyme Therapeutics | 11.73 Bn | 9.97 Bn | 410.50 Mn | 16.04% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.04% |
| Jun 30, 2026 | 15.75% |
| Mar 31, 2026 | 13.42% |
| Dec 31, 2025 | 13.35% |
| Sep 30, 2025 | 27.86% |
| Jun 30, 2025 | 26.22% |
| Mar 31, 2025 | 22.79% |
| Dec 31, 2024 | 21.24% |
| Sep 30, 2024 | 19.20% |
| Jun 30, 2024 | 17.70% |
| Mar 31, 2024 | 17.84% |
| Dec 31, 2023 | 15.53% |
| Sep 30, 2023 | 13.71% |
| Jun 30, 2023 | 13.32% |
| Mar 31, 2023 | 10.26% |
| Dec 31, 2022 | 10.91% |
| Sep 30, 2022 | 11.59% |
| Jun 30, 2022 | 24.88% |
| Mar 31, 2022 | 38.38% |
| Dec 31, 2021 | 35.17% |
API Access
Halozyme Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();